Journal of Nuclear Medicine

Journal of Nuclear Medicine
Title	Journal of Nuclear Medicine
Discipline	Nuclear medicine
Abbreviation	J. Nucl. Med.
Publisher	Society of Nuclear Medicine and Molecular Imaging
Country	United States
Frequency	Monthly
History	1964–present
Impact	11.0
Issn	0161-5505

Contents

Journal of Nuclear Medicine The Journal of Nuclear Medicine is a peer‑reviewed medical journal publishing clinical and research advances in nuclear medicine and molecular imaging. Established in the 1960s, it serves as the official publication of the Society of Nuclear Medicine and Molecular Imaging and disseminates original research, reviews, and guidelines that inform practice at institutions such as Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital. Readers include clinicians and investigators affiliated with National Institutes of Health, European Association of Nuclear Medicine, American College of Radiology, and academic centers worldwide like Stanford University and Harvard Medical School.

History

The journal was founded amid rapid postwar development in radionuclide applications driven by work at Brookhaven National Laboratory, Oak Ridge National Laboratory, and Lawrence Berkeley National Laboratory. Early contributors and seminal figures included researchers from University of Pennsylvania, University of Michigan, and University College London whose studies paralleled discoveries by scientists associated with World War II‑era projects and later collaborations with International Atomic Energy Agency. Throughout the 1970s and 1980s the journal chronicled advances tied to innovations at Siemens Healthineers, GE Healthcare, and Philips Healthcare as clinical PET and SPECT modalities expanded at centers like Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. Editorial stewardship changed hands across editors with appointments linked to institutions such as Yale University, University of California, Los Angeles, and Columbia University.

Content spans clinical trials, translational research, methodological studies, and consensus statements addressing oncology, cardiology, neurology, and infectious disease imaging as practiced at places like Cleveland Clinic, Royal Marsden Hospital, and Mount Sinai Hospital. Topics frequently cross‑reference molecular biology advances from Cold Spring Harbor Laboratory, radiochemistry developments from Los Alamos National Laboratory, and regulatory context involving Food and Drug Administration and European Medicines Agency approvals. The journal features studies on radiotracers developed in collaboration with laboratories such as Lawrence Livermore National Laboratory, imaging biomarkers validated at Memorial Sloan Kettering Cancer Center, and multicenter trials coordinated with networks like National Cancer Institute and Cancer Research UK.

Published monthly by the Society of Nuclear Medicine and Molecular Imaging, the journal maintains peer review processes typical of major biomedical journals like The Lancet, New England Journal of Medicine, and Journal of Clinical Oncology. Editors have been drawn from faculty at Johns Hopkins University, University of Oxford, Karolinska Institutet, and Imperial College London. The editorial board includes members with affiliations to European Association of Nuclear Medicine, American Society of Clinical Oncology, and national academies such as the National Academy of Medicine. Production and distribution intersect with publishers and vendors including Elsevier, Wiley‑Blackwell, and large academic libraries like Library of Congress and British Library for archiving.

The journal is indexed in major databases and services used by institutions such as PubMed Central, Scopus, Web of Science, and Embase. Bibliographic visibility benefits researchers at centers like Cold Spring Harbor Laboratory, Salk Institute, and Fred Hutchinson Cancer Research Center and is reflected in listings by organizations including Clarivate Analytics and indexing in medical libraries at National Library of Medicine and Wellcome Trust. Abstracting coverage facilitates citation tracking via platforms such as Google Scholar, ResearchGate, and ORCID profiles used by investigators from University of Toronto and University of Sydney.

The journal’s impact is reflected in citation metrics compared with specialty and generalist publications including Radiology, European Journal of Nuclear Medicine and Molecular Imaging, and Journal of Nuclear Cardiology. Influential articles have shaped guidelines from societies like European Society for Medical Oncology and clinical pathways adopted at hospitals such as Cleveland Clinic and UCLA Health. Scholarly reception includes awards and recognitions linked to contributors affiliated with National Institutes of Health and laureates of honors such as the Lasker Award and memberships in the National Academy of Sciences.

Notable publications include early clinical PET studies originating from collaborations between University of Pennsylvania and Brookhaven National Laboratory, tracer development reports from teams at University of California, San Francisco and Vanderbilt University, and multicenter trial results coordinated with National Cancer Institute and Cancer Research UK. Special thematic issues have focused on topics coordinated with conferences such as the SNMMI Annual Meeting, the European Association of Nuclear Medicine Congress, and international symposia hosted by institutions including Karolinska Institutet and McGill University.

Category:Nuclear medicine journals